The Effects of Malaria and Intermittent Preventive Treatment During Pregnancy on Fetal Anemia in Malawi
Author(s) -
Elizabeth T. Rogawski McQuade,
E. Chaluluka,
Malcolm E. Molyneux,
Gaoqian Feng,
Stephen J. Rogerson,
Steven R. Meshnick
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis597
Subject(s) - medicine , malaria , pregnancy , anemia , fetus , obstetrics , intensive care medicine , pediatrics , immunology , genetics , biology
Fetal anemia is common in malarious areas and is a risk factor for infant morbidity and mortality. Malaria during pregnancy may cause decreased cord hemoglobin (Hb) and fetal anemia among newborns. Intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is protective against malaria but may also affect hematopoiesis and contribute to fetal anemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom